Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer-Reference-Cited by-同舟云学术

Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer

Published:2008-06 Issue:9 Volume:44 Page:1229-1237
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Martinez-Balibrea Eva,Abad Albert,Aranda Enrique,Sastre Javier,Manzano Jose Luis,Díaz-Rubio Eduardo,Gómez-España Auxiliadora,Aparicio Jorge,García Teresa,Maestu Inmaculada,Martínez-Cardús Anna,Ginés Alba,Guino Elisabet

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. New systemic frontline treatment for metastatic colorectal carcinoma;Braun;Cancer,2004

2. Update on capecitabine in colorectal cancer;Schmoll;Oncologist,2006

3. Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study Group;Porschen;J Clin Oncol,2007

4. Phase III Study of Capecitabine Plus Oxaliplatin Compared With Continuous-Infusion Fluorouracil Plus Oxaliplatin As First-Line Therapy in Metastatic Colorectal Cancer: Final Report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial

5. Should capecitabine replace infusional fluorouracil and leucovorin when combined with oxaliplatin in metastatic colorectal cancer?;Mayer;J Clin Oncol,2007

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TYMS 3′-UTR Polymorphism: A Novel Association with FOLFIRINOX-Induced Neurotoxicity in Pancreatic Cancer Patients;Pharmaceutics;2021-12-29

2. Genetic Variants in DNA Repair Pathways as Potential Biomarkers in Predicting Treatment Outcome of Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: A Systematic Review;Frontiers in Pharmacology;2020-10-06

3. Anticancer effect of X-Ray triggered methotrexate conjugated albumin coated bismuth sulfide nanoparticles on SW480 colon cancer cell line;International Journal of Pharmaceutics;2020-05

4. XRCC3 Thr241Met and TYMS variable number tandem repeat polymorphisms are associated with time-to-metastasis in colorectal cancer;PLOS ONE;2018-02-02

5. Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial;Annals of Oncology;2018-02